Efficacy of Combining, Sequencing Liver-directed Therapy With Systemic Therapy for Gastrointestinal NETs

Pharmacy Times interviewed Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, on his presentation at the 2021 NANETS Multidisciplinary Neuroendocrine Tumors (NETs) Medical Virtual Symposium discussing sequencing and combination of liver-directed therapy (LDT) with systemic therapies.

During the interview, Gabriel discussed the findings regarding the efficacy of combining and sequencing LDT with systemic therapy when treating patients with gastrointestinal NETs.